gut microbiota
Researchers set up a clinical trial to study how glucocorticoids affected the gut microbiota, metabolism, and immunity in healthy young men.
Federica Facciotti, from University of Milano Bicocca, focuses on how the gut microbiota interacts with immune activation, shaping both chronic inflammatory intestinal disorders and oncology, particularly colorectal cancer.
Gut bacteria help protect the liver by breaking down sorbitol, a sugar made from glucose in the gut.
The researchers created a microbial catalog, which they called HROM (human reference oral microbiome), containing 72,641 high-quality genomes from 3,426 species.
Diet and gut microbes can shape immune cell function and improve responses to anti-cancer therapy.
A gut bacterium, Clostridium steroidoreducens, can chemically modify steroid hormones, including those used to treat IBD.
L. mucosae and L. ruminis can produce serotonin in the gut, where it promotes nerve growth and regulates intestinal motility.
Researchers have found that certain gut bacteria and their metabolites differ between IBS subtypes.
Results of a recent study showed reduced microbial diversity and distinct microbial profile in the two groups of PC patients.
Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.
